Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kecskemet – page 12

139 clinical trials in Kecskemet, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kecskemet at a glance
139
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

139 trials in Kecskemet

Open in trial search

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Antipsychotics
  • Sponsor:Gilead Sciences Inc.

Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Kecskemet

What the registry says about research in the country

01 Oncology Research

Extensive research focusing on innovative treatments for various types of cancer, including breast cancer, lung cancer, and prostate cancer. Studies are evaluating new immunotherapy combinations and targeted therapies.

  • Non-small cell lung cancer treatments
  • Breast cancer therapies
  • Advanced prostate cancer interventions

Multiple trials investigating breakthrough treatments for both early-stage and metastatic cancers.

02 Dermatology Studies

Clinical investigations centered on treating moderate to severe plaque psoriasis and related conditions. Research includes evaluation of novel biological therapies and long-term treatment options.

  • Psoriasis management
  • Psoriatic arthritis treatments
  • Long-term safety studies

Focus on developing more effective treatments for chronic skin conditions.

03 Women's Health

Research spanning reproductive health and women-specific conditions, including contraception and primary dysmenorrhea treatment studies.

  • Contraceptive efficacy trials
  • Menstrual pain management
  • Reproductive health innovations

Evaluating both hormonal and natural treatment approaches for women's health conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.